Workflow
vaccine
icon
Search documents
X @The Wall Street Journal
Breaking: RFK Jr.'s vaccine panel voted to no longer recommend a combined shot for measles, mumps, rubella and varicella for children under age 4 https://t.co/0JEll5wb2x ...
X @Bloomberg
Bloomberg· 2025-09-18 17:40
Robert F. Kennedy Jr.’s hand-selected vaccine advisers questioned the safety of shots administered to millions of children as they prepare for a pivotal vote Thursday that could change how immunizations are given in the US https://t.co/JY3tVzp9Rn ...
RFK Jr.’s shakeup of public health was ‘longtime overdue,’ says physician GOP Rep.
NBC News· 2025-09-17 21:32
And as we mentioned, it has been a very busy day on Capitol Hill. I want to pick back up with Republican Congressman from North Carolina, Greg Murphy. Um, Congressman, thanks for being with us. Thanks for rolling with the breaking news here a little bit.Um, I want to start with that Senate hearing today uh with former CDC director Susan Manarez where she said she was asked to approve every recommendation from this vaccine panel which now includes these um Kennedy appointed vaccine skeptics regardless of the ...
X @The Wall Street Journal
From @WSJopinion: Which is it, Mr. Kennedy: Was President Trump’s vaccine operation a triumph or a government catastrophe?https://t.co/AdqqJWLmt0 ...
Dr. Vin Gupta: What's happening at CDC is impacting what your local pharmacist can do
MSNBC· 2025-08-29 13:45
Chaos is consuming the CDC after the ousting of the AY's director over vaccine policy and the exodus of other officials who resigned in protest. Those officials speaking out yesterday promising to continue the fight from the outside. What makes CDC great are the people that make CDC up, the scientists, everyone that makes this a family.And it's a family that defends our country and the health of our children and the health of adults. You are the people that protect America and America needs to see that you ...
X @Bloomberg
Bloomberg· 2025-06-30 15:40
RFK Jr.'s vaccine advisory panel has already cast aside evidence-based science in favor of anti-vaccine propaganda and misinformation, @lisamjarvis says (via @opinion) https://t.co/Oz2ptUI6up ...
RFK Jr.'s Vaccine Panel Could Make New Recommendations
Bloomberg Television· 2025-06-26 20:44
THERE IS SOME DEBATE OVER IT. TIM: DAMIEN JOINS US. I WANT TO START A LITTLE BIT BACK IN TIME.THE QUESTIONS OVER THE VACCINE SCHEDULE ABOUT YOUNG KIDS. YOU LOOK AT THIS THING, YOUR DOCTOR LOOKS AT THIS THING, THESE ARE THE RECOMMENDED VACCINES AT THIS AGE. THEY WORK IN TANDEM WITH THE AMERICAN ACADEMY OF PEDIATRICS.WHAT IS HAPPENING IN WASHINGTON RIGHT NOW. IT IS RECOMMENDED, BUT NOT REQUIRED, BUT FOR MOST PEOPLE YOU GO TO YOUR PEDIATRICIAN WITH WHAT THEY TELL YOU. THE GROUP OF CDC ADVISORS ARE REOPENING TH ...
RFK Jr. guts CDC’s vaccine panel of independent experts
NBC News· 2025-06-11 00:30
Fierce blowback tonight to HHS Secretary Robert F. Kennedy Jr. .'s decision to remove all members of the CDC's vaccine advisory committee.From public health recommended, if this committee stops recommending vaccines, insurance won't cover it anymore. People will not get it. It will have a real impact on people's access to vaccines.And the American Academy of Pediatrics, I think we're we're likely to see diseases that we've that many people have never seen before or even heard of. Concern from parents. Don G ...
Novavax (NVAX) Beats Q1 Earnings and Revenue Estimates
ZACKS· 2025-05-08 14:16
Financial Performance - Novavax reported quarterly earnings of $2.93 per share, significantly exceeding the Zacks Consensus Estimate of $0.71 per share, and compared to a loss of $1.05 per share a year ago, representing an earnings surprise of 312.68% [1] - The company posted revenues of $666.66 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 215.04%, and compared to year-ago revenues of $93.86 million [2] Market Performance - Novavax shares have declined approximately 26% since the beginning of the year, while the S&P 500 has decreased by 4.3% [3] - The current consensus EPS estimate for the upcoming quarter is $0.07 on revenues of $149.29 million, and for the current fiscal year, it is $0.84 on revenues of $633.26 million [7] Industry Outlook - The Medical - Biomedical and Genetics industry, to which Novavax belongs, is currently ranked in the top 33% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Novavax's stock performance [5]